Duraibabu Prathyusha 4
4 · Organogenesis Holdings Inc. · Filed Feb 20, 2026
Research Summary
AI-generated summary of this filing
Organogenesis (ORGO) Director Prathyusha Receives RSU Award
What Happened
- Director Duraibabu Prathyusha received a grant of 48,828 restricted stock units (RSUs) on Feb 18, 2026. The Form 4 lists the acquisition price as $0.00, reflecting an equity award rather than a market purchase or sale.
Key Details
- Transaction date: February 18, 2026; Form 4 filed February 20, 2026 (within the typical 2-business-day reporting window).
- Grant: 48,828 RSUs; price reported: $0.00; reported dollar value for the transaction: $0.
- Vesting: The RSUs vest in full on February 15, 2027 (per filing footnote).
- Shares owned after the transaction: not specified in the provided filing details.
- Filing type: Award/Grant (code A). No 10b5-1 plan, tax-withholding sale, or late-filing indication noted in the filing.
Context
- RSUs are a form of compensation that convert to shares upon vesting; this award gives Prathyusha the contingent right to receive one Class A share per RSU on vesting (Feb 15, 2027). Such grants are routine compensation for executives or directors and do not directly signal open-market buying or selling by the insider.
Insider Transaction Report
Form 4
Duraibabu Prathyusha
Director
Transactions
- Award
Class A Common Stock
[F1]2026-02-18+48,828→ 247,047 total
Footnotes (1)
- [F1]Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2027.
Signature
/s/ William R. Kolb, Attorney-in-Fact|2026-02-20